These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 23122726)
1. Short-term treatment with metformin suppresses toll like receptors (TLRs) activity in isoproterenol-induced myocardial infarction in rat: are AMPK and TLRs connected? Soraya H; Farajnia S; Khani S; Rameshrad M; Khorrami A; Banani A; Maleki-Dizaji N; Garjani A Int Immunopharmacol; 2012 Dec; 14(4):785-91. PubMed ID: 23122726 [TBL] [Abstract][Full Text] [Related]
2. Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction. Soraya H; Clanachan AS; Rameshrad M; Maleki-Dizaji N; Ghazi-Khansari M; Garjani A Eur J Pharmacol; 2014 Aug; 737():77-84. PubMed ID: 24842192 [TBL] [Abstract][Full Text] [Related]
3. Metformin protects the myocardium against isoproterenol-induced injury in rats through alleviating endoplasmic reticulum stress. Cai H; Zhang G; Chen W; Zhang B; Zhang J; Chang J; Tang C; Qi Y; Yin X Pharmazie; 2014 Jan; 69(1):64-9. PubMed ID: 24601227 [TBL] [Abstract][Full Text] [Related]
4. AMPK activation by metformin inhibits local innate immune responses in the isolated rat heart by suppression of TLR 4-related pathway. Vaez H; Najafi M; Rameshrad M; Toutounchi NS; Garjani M; Barar J; Garjani A Int Immunopharmacol; 2016 Nov; 40():501-507. PubMed ID: 27756052 [TBL] [Abstract][Full Text] [Related]
5. Metformin improves cardiac function in rats via activation of AMP-activated protein kinase. Wang XF; Zhang JY; Li L; Zhao XY; Tao HL; Zhang L Clin Exp Pharmacol Physiol; 2011 Feb; 38(2):94-101. PubMed ID: 21143620 [TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effect of metformin in lipopolysaccharide-induced sepsis via suppression of toll-like receptor 4 (TLR4) in heart. Vaez H; Rameshrad M; Najafi M; Barar J; Barzegari A; Garjani A Eur J Pharmacol; 2016 Feb; 772():115-23. PubMed ID: 26708162 [TBL] [Abstract][Full Text] [Related]
7. Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration. Solskov L; Løfgren B; Kristiansen SB; Jessen N; Pold R; Nielsen TT; Bøtker HE; Schmitz O; Lund S Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):82-7. PubMed ID: 18484962 [TBL] [Abstract][Full Text] [Related]
8. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats. Zhang CX; Pan SN; Meng RS; Peng CQ; Xiong ZJ; Chen BL; Chen GQ; Yao FJ; Chen YL; Ma YD; Dong YG Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):55-62. PubMed ID: 21083698 [TBL] [Abstract][Full Text] [Related]
9. Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation. Huang NL; Chiang SH; Hsueh CH; Liang YJ; Chen YJ; Lai LP Int J Cardiol; 2009 May; 134(2):169-75. PubMed ID: 18597869 [TBL] [Abstract][Full Text] [Related]
13. Metformin inhibits inflammatory response via AMPK-PTEN pathway in vascular smooth muscle cells. Kim SA; Choi HC Biochem Biophys Res Commun; 2012 Sep; 425(4):866-72. PubMed ID: 22898050 [TBL] [Abstract][Full Text] [Related]
14. Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats. Soraya H; Khorrami A; Garjani A; Maleki-Dizaji N; Garjani A Pharmacol Rep; 2012; 64(6):1476-84. PubMed ID: 23406758 [TBL] [Abstract][Full Text] [Related]
15. Metformin Increases Cardiac Rupture After Myocardial Infarction via the AMPK-MTOR/PGC-1α Signaling Pathway in Rats with Acute Myocardial Infarction. Hua J; Liu Z; Liu Z; An D; Lai W; Zhan Q; Zeng Q; Ren H; Xu D Med Sci Monit; 2018 Oct; 24():6989-7000. PubMed ID: 30275441 [TBL] [Abstract][Full Text] [Related]
16. Hypoglycaemic activity and molecular mechanisms of Caesalpinia ferrea Martius bark extract on streptozotocin-induced diabetes in Wistar rats. Vasconcelos CF; Maranhão HM; Batista TM; Carneiro EM; Ferreira F; Costa J; Soares LA; Sá MD; Souza TP; Wanderley AG J Ethnopharmacol; 2011 Oct; 137(3):1533-41. PubMed ID: 21911047 [TBL] [Abstract][Full Text] [Related]
17. Metformin-induced stimulation of AMP-activated protein kinase in beta-cells impairs their glucose responsiveness and can lead to apoptosis. Kefas BA; Cai Y; Kerckhofs K; Ling Z; Martens G; Heimberg H; Pipeleers D; Van de Casteele M Biochem Pharmacol; 2004 Aug; 68(3):409-16. PubMed ID: 15242807 [TBL] [Abstract][Full Text] [Related]
18. Role of activation of 5'-adenosine monophosphate-activated protein kinase in gastric ulcer healing in diabetic rats. Baraka AM; Deif MM Pharmacology; 2011; 88(5-6):275-83. PubMed ID: 22068032 [TBL] [Abstract][Full Text] [Related]
19. The effect of AMP-activated kinase activation on gonadotrophin-releasing hormone secretion in GT1-7 cells and its potential role in hypothalamic regulation of the oestrous cyclicity in rats. Coyral-Castel S; Tosca L; Ferreira G; Jeanpierre E; Rame C; Lomet D; Caraty A; Monget P; Chabrolle C; Dupont J J Neuroendocrinol; 2008 Mar; 20(3):335-46. PubMed ID: 18194429 [TBL] [Abstract][Full Text] [Related]
20. Interaction of glibenclamide and metformin at the level of translation in pancreatic β cells. Wang Q; Cai Y; Van de Casteele M; Pipeleers D; Ling Z J Endocrinol; 2011 Feb; 208(2):161-9. PubMed ID: 21084384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]